Sanofi's head of vaccines leaves for smaller competitor Ipsen
Share:
PARIS (Reuters) - Sanofi's head of vaccines David Loew will quit to become chief executive of Ipsen from July 1, the two French drugmakers said on Friday.The announcement comes at a critical time as Sanofi is working on two vaccine projects to protect against COVID-19, the illness caused by the new coronavirus.Loew, who has been with Sanofi for almost seven years and in charge of the vaccines unit since 2016, will fill a management vacuum at Ipsen, which has been struggling to find a new CEO..